Showing results (2231-2240 of 8,963) with videos related to
Sort By:
Pageof 897
Journal of Hepatology|February 1, 1987
Anti-HD IgM as a marker of chronic delta infectionM Buti, R Esteban, J I Esteban, et al.Journal of Hepatology|October 10, 2021
Exposure to environmental contaminants is associated with altered hepatic lipid metabolism in non-alcoholic fatty liver diseasePartho Sen, Sami Qadri, Panu K Luukkonen, et al.Journal of Hepatology|October 14, 2021
Dopamine receptor D2 antagonism normalizes profibrotic macrophage-endothelial crosstalk in non-alcoholic steatohepatitisJie Qing, Yafeng Ren, Yuwei Zhang, et al.Journal of Hepatology|April 11, 2022
Rare ATG7 genetic variants predispose patients to severe fatty liver diseaseGuido A Baselli, Oveis Jamialahmadi, Serena Pelusi, et al.Journal of Hepatology|April 28, 2022
Feasibility of hepatitis B elimination in high-income countries with ongoing immigrationFeng Tian, Jordan J Feld, Zeny Feng, et al.Journal of Hepatology|July 20, 2010
HBV reactivation after fludarabine chemotherapy identified on investigation of suspected transfusion-transmitted Hepatitis B virusJ P Power, M El Chaar, J Temple, et al.Journal of Hepatology|June 22, 2010
Thrombocytopenia and the risk of bleeding during treatment with peginterferon alfa and ribavirin for chronic hepatitis CRobert Roomer, Bettina E Hansen, Harry L A Janssen, et al.Journal of Hepatology|July 13, 2010
Induced pluripotent stem cells: a new era for hepatologySamira Asgari, Behshad Pournasr, Ghasem Hosseini Salekdeh, et al.Journal of Hepatology|July 13, 2010
Experimentally induced liver metastases from colorectal cancer can be prevented by mononuclear phagocyte-mediated monoclonal antibody therapyGerben J van der Bij, Marijn Bögels, Marielle A Otten, et al.Journal of Hepatology|October 16, 2010
Cholesterol synthesis is increased and absorption decreased in non-alcoholic fatty liver disease independent of obesityPiia Simonen, Anna Kotronen, Maarit Hallikainen, et al.Pageof 897